Literature DB >> 26872731

Prospective Validation of a Novel Vasoactive-Ventilation-Renal Score as a Predictor of Outcomes After Pediatric Cardiac Surgery.

Kyle G Miletic1, Ralph E Delius2, Henry L Walters2, Christopher W Mastropietro3.   

Abstract

BACKGROUND: We sought to further validate the novel vasoactive-ventilation-renal (VVR) score in a prospective study of a heterogeneous cohort of children undergoing cardiac surgery that includes patients with single-ventricle anatomy and residual mixing lesions.
METHODS: We prospectively performed an observational study of all children less than 18 years of age who underwent surgery for congenital heart disease at our center from November 2013 to June 2014. We calculated VVR score as follows: vasoactive-inotrope score + ventilation index + (change in serum creatinine from baseline × 10). Admission, peak, and 48-hour measurements were recorded. Outcomes of interest were prolonged duration of mechanical ventilation and intensive care unit and hospital stays, represented by the upper 25% for all patients. Areas under the receiver-operating characteristic curves (AUC) were determined for all study timepoints and outcome variables.
RESULTS: Ninety-two patients were analyzed; their median age was 0.65 (range, 3 days to 17.9 years), and 17 (18%) had single-ventricle anatomy. The VVR measurements outperformed vasoactive-inotrope scores in isolation at all timepoints, with higher AUC values for all outcomes. Of the three timepoints assessed, the 48-hour VVR score most consistently predicted poor outcome, especially with regard to prolonged duration of mechanical ventilation (AUC 0.980) and prolonged intensive care unit stay (AUC 0.919).
CONCLUSIONS: In a heterogeneous population of children undergoing cardiac surgery, the 48-hour VVR score was a very strong predictor of outcomes, and outperformed the more traditional vasoactive-inotrope score. The VVR score, therefore, represents a novel and potentially powerful means of predicting clinical outcomes relatively early in the hospital course of these patients.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26872731     DOI: 10.1016/j.athoracsur.2015.11.006

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Evaluation of the Performance of Vasoactive Ventilation Renal Score in Predicting the Duration of Mechanical Ventilation and Intensive Care Hospitalization After Pediatric Cardiac Surgery.

Authors:  Merve Havan; Burak Emekli; Serhan Özcan; Emrah Gün; Edin Botan; Mehmet Ramoğlu; Selen Karagözlü; Nur Dikmen; Beyza Doğanay Erdoğan; Tayfun Uçar; Zeynep Eyileten; Ercan Tutar; Adnan Uysalel; Tanıl Kendirli
Journal:  Pediatr Cardiol       Date:  2022-09-29       Impact factor: 1.838

2.  Acute Kidney Injury and Fluid Overload in Pediatric Cardiac Surgery.

Authors:  Michael A Carlisle; Danielle E Soranno; Rajit K Basu; Katja M Gist
Journal:  Curr Treat Options Pediatr       Date:  2019-08-28

3.  Virtual 3D Modeling of Airways in Congenital Heart Defects.

Authors:  Simone Speggiorin; Saravanan Durairaj; Branko Mimic; Antonio F Corno
Journal:  Front Pediatr       Date:  2016-10-26       Impact factor: 3.418

4.  Vasoactive-Inotropic Score and Vasoactive-Ventilation-Renal Score as Outcome Predictors for Children on Extracorporeal Membrane Oxygenation.

Authors:  Ira Shukla; Sheila J Hanson; Ke Yan; Jian Zhang
Journal:  Front Pediatr       Date:  2021-11-30       Impact factor: 3.418

5.  Vasoactive-ventilation-renal score in predicting outcome postcardiac surgery in children.

Authors:  Shahzad Alam; Shalini Akunuri; Akanksha Jain; Rufaida Mazahir; Rajesh Hegde
Journal:  Int J Crit Illn Inj Sci       Date:  2018 Jul-Sep

6.  What's New in Critical Illness and Injury Science?: Revalidation of vasoactive-ventilation-renal scoring in predicting outcome in postcardiac surgery children and the importance of replicating studies.

Authors:  Thomas John Papadimos
Journal:  Int J Crit Illn Inj Sci       Date:  2018 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.